查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1829583

分子育種市場（按作物類型、產品類型、最終用戶和應用）—2025-2032 年全球預測

Molecular Breeding Market by Crop Type, Product Type, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年分子育種市場將成長至 111.7 億美元，複合年成長率為 12.56%。

主要市場統計數據
基準年2024年 43.3億美元
預計2025年 48.7億美元
預測年份：2032年 111.7億美元
複合年成長率（%） 12.56%

綜合運用技術與管理能力，加速分子育種，重組作物改良管道

分子育種是基因組學、高通量表現型分析和計算分析的交叉領域，為加速作物改良奠定了基礎。過去十年，定序通量的提升、基因型鑒定成本的降低以及表現型分析的改進，徹底改變了育種流程的設計和執行方式，使研發團隊能夠縮短育種週期、提高選擇精度，並在不同的環境條件下檢驗複雜性狀。

本報告綜合了分子育種生態系統的發展，揭示了技術整合如何改變相關人員的行為、資本配置和夥伴關係模式。報告檢驗了漸進式流程改善和模式轉移，這些改進和轉變使得更具預測性的育種策略成為可能。重要的是，本分析將最新的技術進步置於實際營運中，從供應鏈依賴到監管約束，為讀者提供了一個將方法層面的創新與商業性成果聯繫起來的整體觀點。

為企業領導者、投資者和研究負責人提供的背景介紹，組裝了變革的關鍵促進因素、典型的應用路徑以及值得策略關注的新興價值池，為後續章節奠定了基礎。透過建立這一基準，後續章節闡明了哪些領域最有可能出現顛覆，以及哪些領域需要深思熟慮的干涉才能帶來顯著回報。

技術、監管和商業性動態的整合如何重塑整個分子育種生態系統的營運控制和競爭優勢

在技​​術、監管和商業性動態整合的推動下，分子育種領域正在經歷一系列變革。基因型鑒定平台正從專業化的核心設施轉向可用於分散育種站的模組化設備，將資料產生的控制權更緊密地轉移到育種者手中。基於影像和感測器輔助的表現型分析技術的同步發展正在提高時間解析度和性狀保真度，從而能夠發現先前在田間試驗中被掩蓋的細微基因型與環境相互作用。

同時，軟體和分析技術正在從說明報告發展到整合多組體學層面的預測建模和決策支援系統。這種轉變鼓勵多學科團隊將資料科學家納入育種計劃，並推動了對可互通資料標準和雲端原生架構的需求。法律規範也在不斷調整。各國司法管轄區對基因編輯品種的途徑進行了明確，這正在刺激投資，並促進更快的測試和商業化進程。

商業性，夥伴關係正變得更加靈活和以結果為導向，許可、數據共用和基於績效的合約正成為協調技術提供者、種苗公司和研究機構之間獎勵的首選機制。這些轉變正在共同改變該產業的時機、風險分配和競爭優勢的定位。

評估2025年美國關稅如何改變分子育種相關人員的採購、供應鏈彈性和營運時間表

美國關稅於2025年生效，對分子育種相關人員的採購、供應鏈彈性和商業化時間表產生了連鎖影響。實驗室設備組件和某些特殊耗材的關稅增加了設備和試劑的到岸成本，促使採購團隊重新評估籌資策略和庫存政策。因此，一些組織轉向多方採購和近岸外包以降低風險，而另一些組織則延長了設備生命週期並加快了對替代供應商的檢驗。

這些貿易政策變化也提高了關鍵設備和高價值耗材國內製造能力的重要性。擁有國內生產或長期供應商夥伴關係的公司獲得了採購優勢，而依賴單一來源進口的小型研究機構則遭遇了計劃延期和營運成本上升。依賴國際測試網路的種苗公司和育種項目也面臨更高的物流成本和更複雜的海關程序，改變了2025年周期的測試計劃和時間表。

在財務方面，不斷變化的關稅環境促使資本配置轉向供應鏈彈性和供應商多元化。企業優先投資於供應商資質認證、庫存擴張和應急計劃，以維持育種計劃。雖然這些措施在短期內成本高昂，但它們降低了嚴重中斷的風險，並為能夠提供一體化採購解決方案、在地化和捆綁服務模式的供應商創造了機會。展望未來，相關人員需要在成本壓力與營運需求之間取得平衡，以維持高通量基因型鑒定和表現型分析能力。

綜合細分分析揭示了作物類型、產品結構、最終用戶優先順序和應用領域如何推動差異化採用和容量需求

關鍵細分分析揭示了不同作物類型、產品形態、最終用戶和應用領域的差異化採用模式和策略重點。作物專案顯示，穀物正在大力投資高通量基因型鑒定和大規模田間表現型分析，以提高累積產量；而水果和蔬菜則優先考慮性狀特異性編輯和需要精細表現型分析的品質指標。油籽計畫正在平衡性狀複雜性和市場特定的性狀組合；豆類計畫則越來越注重抗逆性研究，需要對每個基因型進行深入的環境測試。

產品類型在採購和部署方面呈現出明顯差異：套件和試劑等耗材是決定通量的經常性營運成本，而微陣列掃描儀、PCR系統和定序儀等設備則決定了核心競爭力和資本密集度。生技公司優先考慮平台擴充性和智慧財產權保護，研究機構重視方法檢驗和開放科學合作，種苗公司重視育種流程整合和法規遵循。

應用主導的細分揭示了科學研究工作的重點。例如，抗病計劃需要高解析度的標記-性狀關聯和功能檢驗，抗逆性舉措依賴多環境測試和感測器主導的表現型分析，而產量改進項目則整合了複雜的基因組預測模型和管理實踐數據。這些細分視角揭示了投資和夥伴關係在哪些方面最有效，以及哪些方面的能力差距阻礙了進展。

美洲、中東和非洲以及亞太地區的區域動態和差異化採用模式將影響技術部署和夥伴關係策略

區域動態對分子育種領域的技術採用、監管格局和投資流向有顯著的影響。在美洲，大規模的商業化育種運作以及某些基因編輯方法相對有利的法規環境，支持了整合基因型鑒定和表現型分析平台的早期應用。相較之下，歐洲、中東和非洲的監管立場和研究重點各不相同，存在一些先進的學術合作領域，市場獎勵也各不相同，並且越來越重視應對氣候誘發壓力的韌性性狀。

亞太地區以其公共育種舉措、快速現代化的私營種子產業以及不斷擴大的國內實驗室設備生產能力而脫穎而出。區域供應鏈和貿易關係也會影響籌資策略。跨區域運作的組織通常採用混合部署模式，將集中式資料分析與本地樣本採集和測試結合。這些地理因素決定了組織優先考慮基礎設施投資、人才招募和夥伴關係關係建設，以符合監管、農藝和市場現實。

技術提供者、研究機構和商業育種者之間的策略行動和能力投資將決定新的競爭優勢

領先的分子育種公司正在部署各種策略以獲得競爭優勢：定向收購以整合平台功能；建立合作夥伴關係以共用風險並加速檢驗；以及大力投資軟體和資料科學，將海量資料集轉化為營運決策。擁有多元化產品組合的商業公司正在將儀器銷售與經常性耗材收入和服務合約結合，以平滑收益週期並將自身融入客戶工作流程。

科學研究機構和合約服務供應商正在透過提供模組化服務包來應對這項挑戰，這些服務包降低了小型育種專案的進入門檻，同時為大型客戶保持了高通量能力。智慧財產權策略也在不斷發展，科研機構選擇性地保護核心演算法和性狀連鎖標記，同時加入協作資料共用聯盟以獲取更廣泛的訓練資料集。那些優先考慮互通性、強大的檢驗和強大的客戶支援的公司，育種客戶的留存率正在提高，並創造了從發現到商業化的長期夥伴關係機會。

為產業領導者提供可行的策略重點，以降低營運風險、加速採用並將技術進步轉化為可重複的育種成果

產業領導者應優先考慮切實可行的措施，將技術潛力轉化為可重複的商業性成果。首先，投資可互通的資料架構和清晰的資料管治框架，將加速多試驗分析，並實現跨專案可擴展的基因組預測。其次，實現關鍵設備和耗材供應鏈的多元化，確保本地或多家供應商的供應，可以降低營運風險，並保護育種計畫免受貿易和物流衝擊的影響。第三，建構商業協議，透過基於里程碑的合作和成果共用機制來協調獎勵，可以降低准入門檻，並將資源集中用於高影響力的目標。

此外，組織應透過聘請融合育種專業知識、資料科學和產品管理的多學科團隊來擴展其內部能力，以確保分析結果能夠融入育種決策。與服務供應商建立策略夥伴關係可以創造靈活的能力，而不會削弱核心競爭力。在代表性環境中進行檢驗測試的定向投資可以增強監管提交和市場信譽。最後，領導者必須採用投資組合思維，在顛覆性技術的探索與核心流程的精簡之間取得平衡，即使在不斷變化的外部環境中也能保持持續的進步。

結合專家訪談、文獻綜合和三段論檢驗的穩健混合方法研究途徑可確保獲得可操作和可複製的見解

該研究將對高級研發領導、採購經理和商業策略負責人的初步訪談與對同行評審文獻、專利申請和上市公司資訊披露的二次分析相結合。初步資訊包括結構化訪談，以檢驗採用障礙、採購行為和夥伴關係模式；二次資訊則包括對基因型鑒定、表現型和分析領域的技術背景和趨勢的檢驗。

數據整合強調定性洞察與記錄證據的交叉檢驗。調查方法保障措施包括：將供應商訴求與使用者體驗進行三角檢驗；進行時間最後覆核以確保研究結果的時效性；以及進行敏感度評估以確定不確定性領域。分析方法將訪談的主題編碼與技術能力的結構化映射相結合，使我們能夠突出宏觀趨勢和營運優勢。調查方法優先考慮透明度、可複製性和與尋求可行策略和投資指南的決策者的相關性。

全面了解技術整合、營運彈性和自適應商業模式如何決定分子育種的長期成功。

分子育種正進入成熟期，其特徵是基因組學、表現型組學和分析學的緊密結合，它們共同重新定義了性狀的發現、檢驗和應用方式。技術進步、供應鏈調整和商業模式不斷發展的累積效應，預示著一個更模組化、互聯互通的育種生態系統。積極擁抱資料互通性、供應商多元化和跨學科人才的利益相關人員，將有望從加速育種週期和提高選擇準確性中獲益。

同時，貿易政策、不斷變化的法規以及氣候變遷等外部因素將繼續塑造營運風險和戰略機會。將嚴謹的技術與靈活的商業模式結合的組織將能夠緩解短期干擾並保持長期價值創造。總而言之，未來幾年，那些將平台級進展轉化為強大的育種產品線、檢驗的性狀組合以及能夠滿足農民和消費者需求的連貫上市計劃的公司將獲得豐厚的回報。

目錄

第1章 引言

第2章分析方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 透過整合 CRISPR 鹼基編輯加速小麥和水稻的多性狀改良
  • 引入人工智慧驅動的表現型數據分析，用於大豆育種流程中的預測選擇
  • 部署泛基因組組裝以識別番茄品種中的新型抗病等位基因
  • 在玉米計畫中實施與無人機表現型分析相結合的基因組選擇模型
  • 應用基於單倍型的基因組預測提高高粱品種的耐旱性

第6章：美國關稅的累積影響（2025年）

第7章：人工智慧（AI）的累積影響（2025年）

第8章 分子育種市場（依作物類型）

  • 序列
  • 水果和蔬菜
  • 油籽
  • 脈衝

第9章分子育種市場：依產品類型

  • 耗材
    • 套件
    • 試劑
  • 裝置
    • 微陣列掃描儀
    • PCR體系
    • 序列器
  • 服務
    • 基因型鑒定
    • 表現型分析
  • 軟體
    • 生物資訊學工具
    • 數據分析平台

第 10 章 分子育種市場（依最終使用者）

  • 生技公司
  • 研究所
  • 種子公司

第 11 章分子育種市場：依應用

  • 抗病性
  • 抗壓能力
  • 產量提高

第12章分子育種市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章分子育種市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 分子育種市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章競爭格局

  • 市佔率分析（2024年）
  • FPNV定位矩陣（2024年）
  • 競爭分析
    • Corteva, Inc.
    • Syngenta AG
    • Groupe Limagrain
    • Bayer CropScience AG
    • KWS SAAT SE & Co. KGaA
    • Land O'Lakes, Inc.
    • BASF SE
    • Vilmorin & Cie
    • DLF-A/S
    • Sakata Seed Corporation
Product Code: MRR-43539E5D2DE9

The Molecular Breeding Market is projected to grow by USD 11.17 billion at a CAGR of 12.56% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.33 billion
Estimated Year [2025] USD 4.87 billion
Forecast Year [2032] USD 11.17 billion
CAGR (%) 12.56%

A comprehensive orientation to the integrated technological and operational forces accelerating molecular breeding and reshaping crop improvement pipelines

Molecular breeding sits at the convergence of genomics, high-throughput phenotyping, and computational analytics, forming a foundation for accelerated crop improvement. Over the last decade, improvements in sequencing throughput, reductions in genotyping costs, and refinements in phenotype acquisition have collectively transformed how breeding pipelines are designed and executed. Consequently, research and development teams can compress breeding cycles, enhance selection accuracy, and validate complex traits under diverse environmental scenarios.

This report synthesizes developments across the molecular breeding ecosystem, articulating how technology integration is modifying stakeholder behavior, capital allocation, and partnership models. It examines both incremental process improvements and paradigm shifts that are enabling more predictive breeding strategies. Importantly, the analysis situates recent technological advances within operational realities, from supply chain dependencies to regulatory constraints, offering readers a holistic view that links method-level innovation to commercial outcomes.

Contextualized for corporate leaders, investors, and research directors, the introduction frames the subsequent chapters by outlining the principal drivers of change, typical adoption pathways, and emergent value pools that merit strategic attention. By establishing this baseline, subsequent sections highlight where disruption is most likely to occur and where deliberate intervention can yield outsized returns.

How converging technological, regulatory, and commercial dynamics are reorganizing operational control and competitive advantage across molecular breeding ecosystems

The molecular breeding landscape is undergoing a series of transformative shifts driven by converging technological, regulatory, and commercial dynamics. Genotyping platforms have migrated from specialized core facilities into modular instruments that can be adopted in decentralized breeding stations, thereby shifting control of data generation closer to breeders. Parallel advances in image-based and sensor-enabled phenotyping are increasing temporal resolution and trait fidelity, enabling discovery of subtle genotype-by-environment interactions that were previously masked in field trials.

At the same time, software and analytics have evolved from descriptive reporting toward predictive modeling and decision-support systems that integrate multi-omic layers. This transition has encouraged cross-disciplinary teams to embed data scientists within breeding programs, fueling demand for interoperable data standards and cloud-native architectures. Regulatory frameworks are also adapting; jurisdictions that clarify pathways for gene-edited varieties are catalyzing investment and facilitating faster trials and commercialization.

Commercially, partnerships are more fluid and outcome-oriented, with licensing, data-sharing, and outcome-based contracts emerging as preferred mechanisms to align incentives across technology providers, seed companies, and research institutions. Together, these shifts are transforming timing, risk allocation, and the locus of competitive advantage within the sector.

Assessment of how the 2025 United States tariff measures altered procurement, supply chain resilience, and operational timelines for molecular breeding stakeholders

United States tariff actions implemented in 2025 have produced a cascade of effects across procurement, supply chain resilience, and commercialization timelines for molecular breeding stakeholders. Tariffs on laboratory equipment components and certain specialty consumables have increased landed costs for instruments and reagents, prompting procurement teams to reassess sourcing strategies and inventory policies. As a result, some organizations have shifted toward multi-sourcing and nearshoring to mitigate exposure, while others have extended equipment life cycles and accelerated validation of alternative suppliers.

These trade policy changes have also amplified the importance of domestic manufacturing capacity for critical instrumentation and high-value consumables. Firms with in-country production or long-term supplier partnerships have gained procurement leverage, whereas smaller research outfits reliant on single-source imports experienced project delays and higher operating expenses. In turn, seed companies and breeding programs that depend on international trial networks encountered higher logistical costs and more complex customs procedures, which altered trial planning and timing in the 2025 cycle.

Financially, the tariff environment has shifted capital allocation toward supply chain flexibility and vendor diversification. Companies prioritized investments in vendor qualification, extended inventory, and contingency planning to preserve breeding timelines. While these measures incurred short-term costs, they reduced the risk of severe disruptions and created opportunities for suppliers that could offer integrated procurement solutions, localization, or bundled service models. Going forward, stakeholders will need to balance cost pressures with the operational imperative to maintain high-throughput genotyping and phenotyping capabilities.

Integrated segmentation analysis revealing how crop types, product architectures, end-user priorities, and application areas drive differentiated adoption and capability needs

Key segmentation analysis reveals differentiated adoption patterns and strategic priorities across crop types, product forms, end users, and application areas. Crop-focused programs show that cereals often attract high-throughput genotyping and large-scale field phenotyping investments aimed at cumulative yield gains, while fruits and vegetables prioritize trait-specific edits and quality metrics that require fine-grained phenotyping. Oilseeds programs balance trait complexity with market-specific trait stacks, and pulses are increasingly the focus of stress-tolerance efforts that require concentrated genotype-by-environment trials.

Product-type segmentation demonstrates clear distinctions in procurement and deployment. Consumables, including kits and reagents, are the recurring operational expense that determines throughput; instruments such as microarray scanners, PCR systems, and sequencers define core capability and capital intensity; services spanning genotyping and phenotyping create flexible capacity and access to expertise; and software, from bioinformatics tools to data analysis platforms, drives the translation of raw data into selection decisions. End-user segmentation further differentiates needs: biotechnology firms prioritize platform scalability and IP protection, research institutions emphasize methodological validation and open-science collaboration, and seed companies focus on integration into breeding pipelines and regulatory compliance.

Application-led segmentation highlights where scientific efforts concentrate: disease resistance projects demand high-resolution marker-trait associations and functional validation, stress tolerance initiatives rely on multi-environment trials and sensor-driven phenotyping, and yield enhancement programs integrate complex genomic prediction models with management practice data. These segmentation lenses together expose where investments and partnerships are most effective and where capability gaps constrain progress.

Regional dynamics and differentiated adoption patterns across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape technology deployment and partnership strategies

Regional dynamics exert a strong influence on technology adoption, regulatory posture, and investment flows across the molecular breeding landscape. In the Americas, large commercial breeding operations and a relatively favorable regulatory environment for certain gene-editing approaches have driven early adoption of integrated genotyping and phenotyping platforms, while strong private-sector R&D spending has supported rapid scale-up of field trials and commercialization pathways. In contrast, Europe, the Middle East & Africa present a heterogeneous mix of regulatory stances and research priorities, with pockets of advanced academic collaboration, variable market incentives, and an increasing focus on resilience traits to address climate-driven stressors.

Asia-Pacific stands out for its combination of significant public-sector breeding initiatives, rapidly modernizing private seed industries, and growing domestic manufacturing capacity for lab instrumentation. Regional supply chains and trade relationships also influence procurement strategies; organizations operating across multiple regions often adopt hybrid deployment models that combine centralized data analytics with localized sample collection and trial execution. These geographic considerations shape where organizations prioritize infrastructure investment, talent recruitment, and partnership building to align with regulatory, agronomic, and market realities.

Strategic behaviors and capability investments among technology providers, research institutions, and commercial breeders that define emerging competitive advantage

Leading organizations in molecular breeding are deploying a mixture of strategic moves to secure competitive positions: targeted acquisitions to integrate platform capabilities, alliance formation to share risk and accelerate validation, and focused investments in software and data science to translate large datasets into operational decisions. Commercial players with diversified portfolios are coupling instrument sales with recurring consumable revenues and service contracts, thereby smoothing revenue cycles and embedding themselves into customer workflows.

Research institutions and contract service providers are responding by offering modular service packages that reduce barriers to entry for smaller breeding programs while preserving high-throughput capacity for larger clients. Intellectual property strategies are evolving as well, with organizations selectively protecting core algorithms and trait-linked markers while participating in collaborative data-sharing consortia to access broader training datasets. Companies that prioritize interoperability, robust validation, and strong customer support have improved retention rates among breeding customers, creating opportunities for long-term partnerships that extend from discovery through commercialization.

Actionable strategic priorities for industry leaders to de-risk operations, accelerate adoption, and convert technological advances into repeatable breeding outcomes

Industry leaders should prioritize actionable steps that convert technological potential into repeatable commercial outcomes. First, investing in interoperable data architectures and clear data governance frameworks will accelerate multi-trial analytics and enable scalable genomic prediction across programs. Second, diversifying supply chains for critical instruments and consumables while qualifying local or multiple suppliers will reduce operational risk and protect breeding schedules from trade and logistic shocks. Third, structuring commercial agreements to align incentives-through milestone-based collaborations or outcome-sharing mechanisms-will lower barriers to access and concentrate resources on high-impact objectives.

Furthermore, organizations should expand internal capabilities by hiring cross-disciplinary teams that blend breeding expertise, data science, and product management to ensure that analytical outputs are translated into breeding decisions. Strategic partnerships with service providers can create flexible capacity without diluting core competencies, and targeted investment in validation trials across representative environments will strengthen regulatory dossiers and market credibility. Finally, leaders must adopt a portfolio mindset, balancing exploration of disruptive technologies with consolidation of core process efficiencies to maintain consistent progress under changing external conditions.

Robust mixed-method research approach combining expert interviews, literature synthesis, and triangulated validation to ensure actionable and reproducible insights

This research synthesizes primary interviews with senior R&D leaders, procurement managers, and commercial strategy executives, combined with secondary analysis of peer-reviewed literature, patent filings, and public company disclosures. Primary engagement included structured interviews to validate adoption barriers, procurement behaviors, and partnership models, while secondary sources provided technical context and trend validation across genotyping, phenotyping, and analytics domains.

Data synthesis emphasized cross-validation between qualitative insights and documented evidence. Methodological safeguards included triangulation of supplier claims with user experiences, temporal cross-checks to ensure currency of findings, and sensitivity reviews to identify areas of elevated uncertainty. Analytical approaches integrated thematic coding of interviews with structured mapping of technology capabilities, enabling the report to highlight both macro trends and operational levers. The methodology prioritizes transparency, reproducibility, and relevance to decision-makers seeking pragmatic guidance for strategy and investment.

Synthesis of how technological integration, operational resilience, and adaptive commercial models will determine long-term success in molecular breeding

Molecular breeding is entering a maturation phase characterized by tighter integration of genomics, phenomics, and analytics, which together are redefining how traits are discovered, validated, and deployed. The cumulative effect of technological advances, supply chain adjustments, and evolving commercial models points toward more modular yet interconnected breeding ecosystems. Stakeholders that proactively address data interoperability, supplier diversification, and cross-disciplinary talent will be well-positioned to capture the benefits of accelerated breeding cycles and improved selection accuracy.

At the same time, external factors such as trade policy, regulatory evolution, and climate variability will continue to shape operational risk and strategic opportunity. Organizations that combine technical rigor with flexible commercial models can both mitigate short-term disruptions and sustain long-term value creation. In summary, the coming years will reward those who translate platform-level advances into robust breeding pipelines, validated trait packages, and coherent go-to-market programs that respond to farmer and consumer needs.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of CRISPR base editing to accelerate multi-trait improvement in wheat and rice
  • 5.2. Adoption of AI-driven phenomic data analytics for predictive selection in soybean breeding pipelines
  • 5.3. Deployment of pangenome assemblies to identify novel disease resistance alleles in tomato varieties
  • 5.4. Implementation of genomic selection models coupled with UAV-based phenotyping in maize programs
  • 5.5. Application of haplotype-based genomic prediction to improve drought tolerance in sorghum cultivars

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Molecular Breeding Market, by Crop Type

  • 8.1. Cereals
  • 8.2. Fruits & Vegetables
  • 8.3. Oilseeds
  • 8.4. Pulses

9. Molecular Breeding Market, by Product Type

  • 9.1. Consumables
    • 9.1.1. Kits
    • 9.1.2. Reagents
  • 9.2. Instruments
    • 9.2.1. Microarray Scanners
    • 9.2.2. PCR Systems
    • 9.2.3. Sequencers
  • 9.3. Services
    • 9.3.1. Genotyping
    • 9.3.2. Phenotyping
  • 9.4. Software
    • 9.4.1. Bioinformatics Tools
    • 9.4.2. Data Analysis Platforms

10. Molecular Breeding Market, by End User

  • 10.1. Biotechnology Firms
  • 10.2. Research Institutions
  • 10.3. Seed Companies

11. Molecular Breeding Market, by Application

  • 11.1. Disease Resistance
  • 11.2. Stress Tolerance
  • 11.3. Yield Enhancement

12. Molecular Breeding Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Molecular Breeding Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Molecular Breeding Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Corteva, Inc.
    • 15.3.2. Syngenta AG
    • 15.3.3. Groupe Limagrain
    • 15.3.4. Bayer CropScience AG
    • 15.3.5. KWS SAAT SE & Co. KGaA
    • 15.3.6. Land O'Lakes, Inc.
    • 15.3.7. BASF SE
    • 15.3.8. Vilmorin & Cie
    • 15.3.9. DLF-A/S
    • 15.3.10. Sakata Seed Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MOLECULAR BREEDING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. MOLECULAR BREEDING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. MOLECULAR BREEDING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MOLECULAR BREEDING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MOLECULAR BREEDING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MOLECULAR BREEDING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CEREALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CEREALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CEREALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CEREALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CEREALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CEREALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY FRUITS & VEGETABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY FRUITS & VEGETABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY FRUITS & VEGETABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY FRUITS & VEGETABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY FRUITS & VEGETABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY OILSEEDS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY OILSEEDS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY OILSEEDS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY OILSEEDS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY OILSEEDS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY OILSEEDS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PULSES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PULSES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PULSES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PULSES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PULSES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PULSES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY MICROARRAY SCANNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY MICROARRAY SCANNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY MICROARRAY SCANNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY MICROARRAY SCANNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY MICROARRAY SCANNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY MICROARRAY SCANNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PCR SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PCR SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PCR SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PCR SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PCR SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEQUENCERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEQUENCERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEQUENCERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEQUENCERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEQUENCERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEQUENCERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY GENOTYPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY GENOTYPING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY GENOTYPING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY GENOTYPING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY GENOTYPING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY GENOTYPING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PHENOTYPING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PHENOTYPING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PHENOTYPING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PHENOTYPING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PHENOTYPING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY PHENOTYPING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOINFORMATICS TOOLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOINFORMATICS TOOLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOINFORMATICS TOOLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOINFORMATICS TOOLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOINFORMATICS TOOLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOINFORMATICS TOOLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DATA ANALYSIS PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DATA ANALYSIS PLATFORMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DATA ANALYSIS PLATFORMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DATA ANALYSIS PLATFORMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DATA ANALYSIS PLATFORMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DATA ANALYSIS PLATFORMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEED COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEED COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEED COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEED COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEED COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY SEED COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DISEASE RESISTANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DISEASE RESISTANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DISEASE RESISTANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DISEASE RESISTANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DISEASE RESISTANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY DISEASE RESISTANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY STRESS TOLERANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY STRESS TOLERANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY STRESS TOLERANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY STRESS TOLERANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY STRESS TOLERANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY STRESS TOLERANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY YIELD ENHANCEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY YIELD ENHANCEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY YIELD ENHANCEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY YIELD ENHANCEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY YIELD ENHANCEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY YIELD ENHANCEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 161. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 162. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 262. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 264. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. MIDDLE EAST MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. AFRICA MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. AFRICA MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. AFRICA MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. AFRICA MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 275. AFRICA MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 276. AFRICA MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 277. AFRICA MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 278. AFRICA MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 279. AFRICA MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 280. AFRICA MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 281. AFRICA MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 282. AFRICA MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 283. AFRICA MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. AFRICA MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. AFRICA MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. AFRICA MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 296. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 297. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 298. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 299. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 300. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 301. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 302. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 303. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 304. ASIA-PACIFIC MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL MOLECULAR BREEDING MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 307. ASEAN MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. ASEAN MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. ASEAN MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. ASEAN MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. ASEAN MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. ASEAN MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 313. ASEAN MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 314. ASEAN MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 315. ASEAN MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 316. ASEAN MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 317. ASEAN MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 318. ASEAN MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 319. ASEAN MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 320. ASEAN MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 321. ASEAN MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 322. ASEAN MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 323. ASEAN MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. ASEAN MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 325. GCC MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 326. GCC MOLECULAR BREEDING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 327. GCC MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. GCC MOLECULAR BREEDING MARKET SIZE, BY CROP TYPE, 2025-2032 (USD MILLION)
  • TABLE 329. GCC MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 330. GCC MOLECULAR BREEDING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 331. GCC MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 332. GCC MOLECULAR BREEDING MARKET SIZE, BY CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 333. GCC MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 334. GCC MOLECULAR BREEDING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 335. GCC MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 336. GCC MOLECULAR BREEDING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 337. GCC MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 338. GCC MOLECULAR BREEDING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 339. GCC MOLECULAR BREEDING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 340. GCC MOLECULAR BREEDING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 341. GCC MOLECULAR BREEDING MARKET SIZE, BY APPLICATION, 2018-202